170 related articles for article (PubMed ID: 12639085)
1. A new paradigm for the treatment of sepsis: is it time to consider combination therapy?
Cross AS; Opal SM
Ann Intern Med; 2003 Mar; 138(6):502-5. PubMed ID: 12639085
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?
Leentjens J; Kox M; van der Hoeven JG; Netea MG; Pickkers P
Am J Respir Crit Care Med; 2013 Jun; 187(12):1287-93. PubMed ID: 23590272
[TBL] [Abstract][Full Text] [Related]
3. A blueprint for a sepsis protocol.
Shapiro NI; Howell M; Talmor D
Acad Emerg Med; 2005 Apr; 12(4):352-9. PubMed ID: 15805328
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive therapies for severe sepsis.
Wittebole X; Collienne C; Castanares-Zapatero D; Laterre PF
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S34-8. PubMed ID: 18715758
[TBL] [Abstract][Full Text] [Related]
5. Advances in sepsis therapy.
Glück T; Opal SM
Drugs; 2004; 64(8):837-59. PubMed ID: 15059039
[TBL] [Abstract][Full Text] [Related]
6. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
Balk RA
Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
[TBL] [Abstract][Full Text] [Related]
8. Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy.
Vazquez-Grande G; Kumar A
Semin Respir Crit Care Med; 2015 Feb; 36(1):154-66. PubMed ID: 25643278
[TBL] [Abstract][Full Text] [Related]
9. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis.
Natanson C; Hoffman WD; Suffredini AF; Eichacker PQ; Danner RL
Ann Intern Med; 1994 May; 120(9):771-83. PubMed ID: 8147551
[TBL] [Abstract][Full Text] [Related]
10. [Clinical management of patients with sepsis].
Weigand MA; Bardenheuer HJ; Böttiger BW
Anaesthesist; 2003 Jan; 52(1):3-22. PubMed ID: 12577161
[TBL] [Abstract][Full Text] [Related]
11. New and emerging therapies for sepsis.
Healy DP
Ann Pharmacother; 2002 Apr; 36(4):648-54. PubMed ID: 11918516
[TBL] [Abstract][Full Text] [Related]
12. [Understanding the pathogenetic mechanisms of SIRS and sepsis and development of innovative therapies of sepsis].
Aikawa N; Fujishima S
Nihon Rinsho; 2004 Dec; 62(12):2173-6. PubMed ID: 15597781
[TBL] [Abstract][Full Text] [Related]
13. Can procalcitonin levels indicate the need for adjunctive therapies in sepsis?
Becze Z; Molnár Z; Fazakas J
Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S13-8. PubMed ID: 26621136
[TBL] [Abstract][Full Text] [Related]
14. Drug intervention trials in sepsis: divergent results.
Polderman KH; Girbes AR
Lancet; 2004 May; 363(9422):1721-3. PubMed ID: 15158636
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa.
Rice TW
Vasc Health Risk Manag; 2006; 2(1):3-18. PubMed ID: 17319465
[TBL] [Abstract][Full Text] [Related]
16. Role of activated protein C in the pathophysiology of severe sepsis.
Dettenmeier P; Swindell B; Stroud M; Arkins N; Howard A
Am J Crit Care; 2003 Nov; 12(6):518-24; quiz 525-6. PubMed ID: 14619357
[TBL] [Abstract][Full Text] [Related]
17. [Fungal sepsis--therapeutical strategy].
Staubach KH
Mycoses; 2005; 48 Suppl 1():72-7. PubMed ID: 15826292
[TBL] [Abstract][Full Text] [Related]
18. Empirical mono- versus combination antibiotic therapy in adult intensive care patients with severe sepsis - A systematic review with meta-analysis and trial sequential analysis.
Sjövall F; Perner A; Hylander Møller M
J Infect; 2017 Apr; 74(4):331-344. PubMed ID: 27919645
[TBL] [Abstract][Full Text] [Related]
19. System interactions.
Singer M
Novartis Found Symp; 2007; 280():252-62; discussion 262-5. PubMed ID: 17380799
[TBL] [Abstract][Full Text] [Related]
20. Sepsis and septic shock: selection of empiric antimicrobial therapy.
Cunha BA
Crit Care Clin; 2008 Apr; 24(2):313-34, ix. PubMed ID: 18361948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
